Life Science REIT (LABS) Stock Chart & Stock Price History GBX 35.70 +0.90 (+2.59%) As of 02/21/2025 11:55 AM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsDividend Life Science REIT Stock Price Performance 5 Day Performance+2.59%1 Month Performance+8.18%3 Month Performance-3.51%6 Month Performance+3.18%Year-To-Date Performance-6.05%1 Year Performance-24.04% Receive LABS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Life Science REIT and its competitors with MarketBeat's FREE daily newsletter. Email Address LABS Stock Chart for Saturday, February, 22, 2025 LABS Chart by TradingView Life Science REIT Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/21/2025GBX 34.80GBX 35.70+2.59%GBX 35.70GBX 34.50434,742 shs£126.75 million02/20/2025GBX 34.60GBX 34.80+0.58%GBX 35GBX 34.70784,345 shs£123.55 million02/19/2025GBX 34.30GBX 34.60+0.87%GBX 34.90GBX 34.46291,360 shs£122.84 million02/18/2025GBX 34.80GBX 34.30-1.44%GBX 34.90GBX 34.10558,823 shs£121.78 million02/17/2025GBX 34.30GBX 34.80+1.46%GBX 34.80GBX 34488,009 shs£123.55 million02/14/2025GBX 34.80GBX 34.30-1.44%GBX 34.80GBX 34.30407,904 shs£121.78 million02/13/2025GBX 35.80GBX 34.80-2.79%GBX 36GBX 34.80434,609 shs£123.55 million02/12/2025GBX 36GBX 35.80-0.56%GBX 36.70GBX 35.70371,907 shs£125.30 million02/11/2025GBX 36GBX 36GBX 36.90GBX 35.90619,971 shs£126 million02/10/2025GBX 36GBX 36GBX 36.80GBX 35.80761,586 shs£126 million Get the Latest News and Ratings for LABS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Life Science REIT and its competitors with MarketBeat's FREE daily newsletter. 02/07/2025GBX 36.20GBX 36-0.55%GBX 37GBX 35.70542,143 shs£126 million02/06/2025GBX 34.70GBX 36.20+4.32%GBX 36.90GBX 34.53526,234 shs£126.70 million02/05/2025GBX 33.70GBX 34.70+2.97%GBX 34.80GBX 33.70671,031 shs£121.45 million02/04/2025GBX 33.80GBX 33.70-0.30%GBX 34.40GBX 33.50610,920 shs£117.95 million02/03/2025GBX 34GBX 33.80-0.59%GBX 33.90GBX 33.41134,163 shs£118.30 million01/31/2025GBX 34GBX 34GBX 34.40GBX 33.50865,838 shs£119 million01/30/2025GBX 33.60GBX 34+1.19%GBX 34.40GBX 33.71280,963 shs£119 million01/29/2025GBX 33.70GBX 33.60-0.30%GBX 34GBX 33.20504,803 shs£117.60 million01/28/2025GBX 33.40GBX 33.70+0.90%GBX 33.80GBX 33.50485,208 shs£117.95 million01/27/2025GBX 33.80GBX 33.40-1.18%GBX 33.80GBX 33817,797 shs£116.90 million01/24/2025GBX 32.90GBX 33.80+2.74%GBX 33.80GBX 33208,515 shs£118.30 million01/23/2025GBX 33GBX 32.90-0.30%GBX 33.21GBX 32.801.04 million shs£115.15 million01/22/2025GBX 32.80GBX 33+0.61%GBX 34.30GBX 32.521.26 million shs£115.50 million01/21/2025GBX 34.50GBX 32.80-4.93%GBX 34.85GBX 32.601.46 million shs£114.80 million Related Companies Impact Healthcare REIT Stock Price Chart Assura Stock Price Chart Primary Health Properties Stock Price Chart Target Healthcare REIT Stock Price Chart Picton Property Income Stock Price Chart Warehouse REIT Stock Price Chart NewRiver REIT Stock Price Chart Mountview Estates Stock Price Chart Custodian Property Income REIT Stock Price Chart LSL Property Services Stock Price Chart Receive LABS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Life Science REIT and its competitors with MarketBeat's FREE daily newsletter. This page (LON:LABS) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Life Science REIT plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Life Science REIT With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
